Last reviewed · How we verify
Suspension Fed State — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Suspension Fed State (Suspension Fed State) — KU Leuven.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Suspension Fed State TARGET | Suspension Fed State | KU Leuven | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Suspension Fed State CI watch — RSS
- Suspension Fed State CI watch — Atom
- Suspension Fed State CI watch — JSON
- Suspension Fed State alone — RSS
Cite this brief
Drug Landscape (2026). Suspension Fed State — Competitive Intelligence Brief. https://druglandscape.com/ci/suspension-fed-state. Accessed 2026-06-09.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing